Shenzhen Neptunus Interlong Co., Ltd. logo

Shenzhen Neptunus Interlong Co., Ltd. (8329)

Market Closed
7 Aug, 08:00
HKEX HKEX
0. 10
HKD
-0
-1.9048%
HKD
231.56M Market Cap
- P/E Ratio
- Div Yield
3.76M Volume
- Eps
0.1 HKD
Previous Close
Add Transaction
Day Range
0.09 0.1
Year Range
0.09 0.18
Want to track 8329 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8329 closed Friday lower at 0.1 HKD, a decrease of -1.9048% from Thursday's close, completing a monthly decrease of -4.6296% or -0.01 HKD. Over the past 12 months, 8329 stock lost -33.9744%.
8329 is not paying dividends to its shareholders.
The last earnings report, released on Aug 21, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

8329 Chart

Shenzhen Neptunus Interlong Co., Ltd. (8329) FAQ

What is the stock price today?

The current price is 0.10 HKD.

On which exchange is it traded?

Shenzhen Neptunus Interlong Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 8329.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 231.56M.

Has Shenzhen Neptunus Interlong Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Shenzhen Neptunus Interlong Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
HKEX Exchange
Y7742Z103 CUSIP
Hong Kong Country
1,471 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Shenzhen Neptunus Interlong Bio-technique Company Limited is a dynamic enterprise that focuses on the research, development, production, and sale of medicines and medical devices across the People's Republic of China. With its roots deeply embedded in Quarry Bay, Hong Kong, it operates as a significant subsidiary under the auspices of Shenzhen Neptunus Bio-engineering Company Limited. The company prides itself on its comprehensive portfolio that addresses various therapeutic needs while simultaneously engaging in the commerce and distribution of healthcare food products. Furthermore, it undertakes endeavors in the realm of biological technology research and development, cementing its position as a notable entity in the biomedical sector.

Products and Services

The company’s offerings can be broadly categorized into two main areas: medicinal products and auxiliary services, each tailored to cater to comprehensive healthcare needs. Below is a breakdown of its primary products and services:

  • Medicines: Shenzhen Neptunus Interlong Bio-technique Company Limited specializes in a wide array of medical treatments targeting critical therapeutic areas such as:
    • Oncology: Developing groundbreaking cancer treatments designed to tackle various forms of the disease with the aim of improving patient survival rates and quality of life.
    • Cardiovascular system: Offering medications that manage heart-related conditions effectively, ensuring better cardiovascular health among patients.
    • Respiratory system: Producing treatments for diseases affecting the lungs and airways, contributing to improved respiratory functions.
    • Digestive system: Providing solutions for digestive disorders, aiding in the overall digestive health and wellness.
    • Mental disorders: Innovating in the realm of mental health, the company boasts a range of medications aimed at combating various mental illnesses, thereby facilitating better mental health outcomes.
  • Medical Devices: The company's dedication extends beyond pharmaceuticals to encompass the development and production of state-of-the-art medical devices. These contributions are pivotal in diagnosing, preventing, and treating diseases, thereby enhancing the overall healthcare landscape.
  • Healthcare Food Products: Acknowledging the intrinsic link between nutrition and health, Shenzhen Neptunus Interlong Bio-technique Company Limited also delves into the healthcare food sector. It aspires to offer food products that not only nourish but also bolster health and well-being among consumers.
  • Biological Technology Research and Development: The company is profoundly invested in the research and development of biological technologies. This venture underscores its commitment to innovating and pioneering advancements in biotechnology, aiming to pave new avenues in medical science and healthcare solutions.

Contact Information

Address: One Taikoo Place
Phone: -